LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 272

Search options

  1. Article: Reducing myocardial infarction by combination of irisin and

    Ding, Chen / Zhang, Chaofeng

    The Chinese journal of physiology

    2023  Volume 66, Issue 5, Page(s) 351–358

    Abstract: Aging, a crucial risk factor for ischemic heart disease, has negative impacts on cardioprotective mechanisms. As such, there is still an unmet requirement to explore potential therapies for improving the outcomes of myocardial ischemia/reperfusion (IR) ... ...

    Abstract Aging, a crucial risk factor for ischemic heart disease, has negative impacts on cardioprotective mechanisms. As such, there is still an unmet requirement to explore potential therapies for improving the outcomes of myocardial ischemia/reperfusion (IR) injury in elderly subjects. Here, we aimed to confirm the cardioprotective function of irisin/Dendrobium nobile Lindl (DNL) combination therapy against myocardial IR injury in aged rats, with a focus on the involvement of pyroptosis and mitophagy. Male aged Wistar rats (22-24 months old, 400-450 g; n = 54) underwent myocardial IR or sham surgery. Before IR operation, rats were pretreated with irisin (0.5 mg/kg, intraperitoneally) and/or DNL (80 mg/kg, orally) for 1 or 4 weeks, respectively, at corresponding groups. Cardiac function, lactate dehydrogenase (LDH) and cardiac-specific isoform of troponin-I (cTn-I) levels, the expression of proteins involved in pyroptosis (nod-like receptor protein-3 (NLRP3), apoptosis-associated speck-like protein, c-caspase-1, and GSDMD-N) and mitophagy (PINK1 and Parkin), and pro-inflammatory cytokines levels were evaluated after 24 h of reperfusion. Irisin/DNL combined therapy significantly restored cardiac function and decreased LDH and cTn-I levels. It also downregulated pyroptosis-related proteins, upregulated PINK1 and Parkin, and decreased pro-inflammatory cytokines secretion. Pretreatment with Mdivi-1, as mitophagy inhibitor, abolished the cardioprotective action of dual therapy. This study revealed the cardioprotective effects of irisin/DNL combination therapy against IR-induced myocardial injury in aged rats, and also showed that the mechanism might be associated with suppression of NLRP3-related pyroptosis through enhancing the activity of the PINK1/Parkin mitophagy. This combination therapy is worthy of further detailed studies due to its potential to alleviate myocardial IR injury upon aging.
    MeSH term(s) Animals ; Male ; Rats ; Aging ; Cytokines ; Dendrobium/chemistry ; Fibronectins ; Mitophagy ; Myocardial Infarction/drug therapy ; Myocardial Infarction/prevention & control ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLR Proteins ; Protein Kinases ; Pyroptosis ; Rats, Wistar ; Reperfusion Injury/metabolism ; Ubiquitin-Protein Ligases/metabolism ; Plant Preparations/pharmacology
    Chemical Substances Cytokines ; Fibronectins ; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLR Proteins ; Protein Kinases (EC 2.7.-) ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Plant Preparations
    Language English
    Publishing date 2023-10-20
    Publishing country India
    Document type Journal Article
    ZDB-ID 966112-8
    ISSN 0304-4920 ; 0300-8525
    ISSN 0304-4920 ; 0300-8525
    DOI 10.4103/cjop.CJOP-D-23-00032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Screening the bioactive compound from Coptis chinensis inflorescence by immobilized peroxisome proliferator-activated receptor-gamma.

    Sun, Jingchun / Zhang, Chaofeng

    Journal of separation science

    2022  Volume 45, Issue 15, Page(s) 2855–2864

    Abstract: Coptis chinensis inflorescence is a by-product of Coptis chinensis Franch and riches in alkaloids. We screened the bioactive compounds in the by-product through an immobilized peroxisome proliferator-activated receptor gamma. The receptor was covalently ... ...

    Abstract Coptis chinensis inflorescence is a by-product of Coptis chinensis Franch and riches in alkaloids. We screened the bioactive compounds in the by-product through an immobilized peroxisome proliferator-activated receptor gamma. The receptor was covalently immobilized on the macroporous silica gel through amino groups to generate the affinity stationary phase and was applied for screening. Berberine, palmatine, and jatrorrhizine were identified as the retained components of the herb on the affinity column. We evaluated the binding of the three bioactive compounds with the receptor by nonlinear chromatography and molecular docking. The affinities of the compounds to the receptor were (1.42 ± 0.10) ×10
    MeSH term(s) Berberine ; Chromatography, High Pressure Liquid/methods ; Coptis/chemistry ; Coptis chinensis ; Drugs, Chinese Herbal/analysis ; Inflorescence/chemistry ; Molecular Docking Simulation ; PPAR gamma
    Chemical Substances Drugs, Chinese Herbal ; PPAR gamma ; Berberine (0I8Y3P32UF)
    Language English
    Publishing date 2022-06-14
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2047990-6
    ISSN 1615-9314 ; 1615-9306
    ISSN (online) 1615-9314
    ISSN 1615-9306
    DOI 10.1002/jssc.202101014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Screening the bioactive compound from Coptis chinensis inflorescence by immobilized peroxisome proliferator‐activated receptor‐gamma

    Sun, Jingchun / Zhang, Chaofeng

    Journal of separation science. 2022 Aug., v. 45, no. 15

    2022  

    Abstract: Coptis chinensis inflorescence is a by‐product of Coptis chinensis Franch and riches in alkaloids. We screened the bioactive compounds in the by‐product through an immobilized peroxisome proliferator‐activated receptor gamma. The receptor was covalently ... ...

    Abstract Coptis chinensis inflorescence is a by‐product of Coptis chinensis Franch and riches in alkaloids. We screened the bioactive compounds in the by‐product through an immobilized peroxisome proliferator‐activated receptor gamma. The receptor was covalently immobilized on the macroporous silica gel through amino groups to generate the affinity stationary phase and was applied for screening. Berberine, palmatine, and jatrorrhizine were identified as the retained components of the herb on the affinity column. We evaluated the binding of the three bioactive compounds with the receptor by nonlinear chromatography and molecular docking. The affinities of the compounds to the receptor were (1.42 ± 0.10) ×10⁸/M, (4.88 ± 0.38) ×10⁷/M, and (1.65 ± 0.13) ×10⁷/M for berberine, palmatine, and jatrorrhizine, with dissociation rate constants of (17.70 ± 0.03) ×10–³/S, (5.18 ± 0.25) ×10–²/S, and (15.7 ± 0.05) ×10–²/S, respectively. Cys285, Arg288, Ile326, Leu330, and His449 in the agonist binding pocket of the receptor participated in the formation of bioactive compound‐receptor conjugates. These data indicated that the immobilized receptor is a reliable alternative for screening the bioactive compounds. In addition, Coptis chinensis inflorescence has the potential to be a source for drug discovery.
    Keywords Coptis chinensis ; agonists ; berberine ; bioactive compounds ; byproducts ; chemical bonding ; chromatography ; dissociation ; drugs ; peroxisome proliferator-activated receptor gamma ; porous media ; separation ; silica gel
    Language English
    Dates of publication 2022-08
    Size p. 2855-2864.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note JOURNAL ARTICLE
    ZDB-ID 2047990-6
    ISSN 1615-9314 ; 1615-9306
    ISSN (online) 1615-9314
    ISSN 1615-9306
    DOI 10.1002/jssc.202101014
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Mogroside ⅡE, an in vivo metabolite of sweet agent, alleviates acute lung injury via Pla2g2a-EGFR inhibition

    Lü, Weichao / Ren, Guoqing / Shimizu, Kuniyoshi / Li, Renshi / Zhang, Chaofeng

    Food Science and Human Wellness. 2024 Jan., v. 13, no. 1 p.299-312

    2024  

    Abstract: In the face of increasingly serious environmental pollution, the health of human lung tissues is also facing serious threats. Mogroside ⅡE (M2E) is the main metabolite of sweetening agents mogrosides from the anti-tussive Chinese herbal Siraitia ... ...

    Abstract In the face of increasingly serious environmental pollution, the health of human lung tissues is also facing serious threats. Mogroside ⅡE (M2E) is the main metabolite of sweetening agents mogrosides from the anti-tussive Chinese herbal Siraitia grosvenori. The study elucidated the anti-inflammatory action and molecular mechanism of M2E against acute lung injury (ALI). A lipopolysaccharide (LPS)-induced ALI model was established in mice and MH-S cells were employed to explore the protective mechanism of M2E through the western blotting, co-immunoprecipitation, and quantitative real time-PCR analysis. The results indicated that M2E alleviated LPS-induced lung injury through restraining the activation of secreted phospholipase A2 type IIA (Pla2g2a)-epidermal growth factor receptor (EGFR). The interaction of Pla2g2a and EGFR was identified by co-immunoprecipitation. In addition, M2E protected ALI induced with LPS against inflammatory and damage which were significantly dependent upon the downregulation of AKT and mTOR via the inhibition of Pla2g2a-EGFR. Pla2g2a may represent a potential target for M2E in the improvement of LPS-induced lung injury, which may represent a promising strategy to treat ALI.
    Keywords Siraitia ; anti-inflammatory activity ; food science ; humans ; lipopolysaccharides ; lungs ; metabolites ; models ; phospholipase A2 ; pollution ; precipitin tests ; quantitative polymerase chain reaction ; Mogroside ⅡE ; Acute lung injury ; Secreted phospholipase A2 type IIA (Pla2g2a) ; Epidermal growth factor receptor (EGFR)
    Language English
    Dates of publication 2024-01
    Size p. 299-312.
    Publishing place Elsevier B.V.
    Document type Article ; Online
    ZDB-ID 2712869-6
    ISSN 2213-4530
    ISSN 2213-4530
    DOI 10.26599/FSHW.2022.9250025
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.

    Lin, Qi / Su, Jianlin / Fang, Yuanyuan / Zhong, Zhihao / Chen, Jie / Zhang, Chaofeng

    Frontiers in oncology

    2024  Volume 14, Page(s) 1344669

    Abstract: Background: S100A8, a calcium-binding protein belonging to the S100 family, is involved in immune responses and multiple tumor pathogens. Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of B-cell lymphoma and remains incurable in ... ...

    Abstract Background: S100A8, a calcium-binding protein belonging to the S100 family, is involved in immune responses and multiple tumor pathogens. Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of B-cell lymphoma and remains incurable in 40% of patients. However, the role of S100A8 and its regulation of the immune response in DLBCL remain unclear.
    Methods: The differential expression of S100A8 was identified via the GEO and TCGA databases. The prognostic role of S100A8 in DLBCL was calculated using the Kaplan-Meier curve. The function enrichment of differentially expressed genes (DEGs) was explored through GO, KEGG, GSEA, and PPI analysis. In our cohort, the expression of S100A8 was verified. Meanwhile, the biological function of S100A8 was applied after the inhibition of S100A8 in an
    Results: S100A8 was significantly overexpressed and related to a poor prognosis in DLBCL patients. Function enrichment analysis revealed that DEGs were mainly enriched in the IL-17 signaling pathway. Our cohort also verified this point.
    Conclusion: Elevated S100A8 expression is associated with a poor prognosis and immune infiltration in DLBCL. Inhibition of S100A8 could promote cell apoptosis and suppress tumor growth. Meanwhile, S100A8 has the potential to be a promising immunotherapeutic target for patients with DLBCL.
    Language English
    Publishing date 2024-02-01
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2024.1344669
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A comprehensive review on the source, ingestion route, attachment and toxicity of microplastics/nanoplastics in human systems.

    Zhu, Yining / Che, Ruijie / Zong, Xinyan / Wang, Jinhan / Li, Jining / Zhang, Chaofeng / Wang, Fenghe

    Journal of environmental management

    2024  Volume 352, Page(s) 120039

    Abstract: Microplastics (MPs)/nanoplastics (NPs) are widely found in the natural environment, including soil, water and the atmosphere, which are essential for human survival. In the recent years, there has been a growing concern about the potential impact of MPs/ ... ...

    Abstract Microplastics (MPs)/nanoplastics (NPs) are widely found in the natural environment, including soil, water and the atmosphere, which are essential for human survival. In the recent years, there has been a growing concern about the potential impact of MPs/NPs on human health. Due to the increasing interest in this research and the limited number of studies related to the health effects of MPs/NPs on humans, it is necessary to conduct a systematic assessment and review of their potentially toxic effects on human organs and tissues. Humans can be exposed to microplastics through ingestion, inhalation and dermal contact, however, ingestion and inhalation are considered as the primary routes. The ingested MPs/NPs mainly consist of plastic particles with a particle size ranging from 0.1 to 1 μm, that distribute across various tissues and organs within the body, which in turn have a certain impact on the nine major systems of the human body, especially the digestive system and respiratory system, which are closely related to the intake pathway of MPs/NPs. The harmful effects caused by MPs/NPs primarily occur through potential toxic mechanisms such as induction of oxidative stress, generation of inflammatory responses, alteration of lipid metabolism or energy metabolism or expression of related functional factors. This review can help people to systematically understand the hazards of MPs/NPs and related toxicity mechanisms from the level of nine biological systems. It allows MPs/NPs pollution to be emphasized, and it is also hoped that research on their toxic effects will be strengthened in the future.
    MeSH term(s) Humans ; Microplastics/toxicity ; Plastics ; Atmosphere ; Energy Metabolism ; Eating ; Water Pollutants, Chemical/toxicity
    Chemical Substances Microplastics ; Plastics ; Water Pollutants, Chemical
    Language English
    Publishing date 2024-01-13
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 184882-3
    ISSN 1095-8630 ; 0301-4797
    ISSN (online) 1095-8630
    ISSN 0301-4797
    DOI 10.1016/j.jenvman.2024.120039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The dual role of 20(S)-protopanaxadiol in alleviating pulmonary fibrosis through the gut-lung axis.

    Ruan, Yang / Ren, Guoqing / Wang, Mingchun / Lv, Weichao / Shimizu, Kuniyoshi / Zhang, Chaofeng

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2024  Volume 129, Page(s) 155699

    Abstract: Background: Pulmonary Fibrosis (PF) is a progressive lung disease characterized by the diffuse interstitial tissue, leading to severe breathing difficulties. The existing treatment methods are primarily aimed at slowing the progression of the disease, ... ...

    Abstract Background: Pulmonary Fibrosis (PF) is a progressive lung disease characterized by the diffuse interstitial tissue, leading to severe breathing difficulties. The existing treatment methods are primarily aimed at slowing the progression of the disease, underscoring the urgent need to discover new drug interventions targeting novel sites. The "gut-lung axis" represents a complex bidirectional communication system where the gut microbiota not only influences lung immunity but also responds to lung-derived signals. Recent advances have uncovered that alterations in gut microbiota composition can significantly impact respiratory diseases, offering new insights into their pathogenesis and potential therapeutic approaches.
    Methods: This study is based on the fundamental concepts of the lung-gut axis and our previous research, further exploring the potential mechanisms of 20(S)-Protopanaxadiol (PPD) in ginseng against PF. We utilized a bleomycin-induced mouse model of PF and employed metabolomics and 16S rRNA sequencing to investigate the pathways through which PPD regulates the pulmonary fibrosis process via the gut-lung axis. Finally, we employed strategies such as antibiotic-induced microbiota disruption and fecal microbiota transplantation (FMT) to provide a comprehensive perspective on how PPD regulates pulmonary fibrosis through gut microbiota.
    Results: The results of the bleomycin (BLM) mouse model of PF proved that PPD can directly act on the glycolysis- related metabolic reprogramming process in lung and the AMPK/STING pathway to improve PF. Combined the analysis of gut microbiota and related metabolites, we found that PPD can regulate the process of PF through the gut-lung axis target points G6PD and SPHK1. FMT and antibiotic-induced microbiota disruption further confirmed intermediate effect of gut microbiota in PF process and the treatment of PPD. Our study suggests that PPD can alleviate the process of pulmonary fibrosis either by directly acting on the lungs or by regulating the gut microbiota.
    Conclusion: This study positions PPD as a vanguard in the therapeutic landscape for pulmonary fibrosis, offering a dual mechanism of action that encompasses both modulation of gut microbiota and direct intervention at molecular targets. These insights highlight the immense therapeutic potential of harnessing the gut-lung axis.
    Language English
    Publishing date 2024-05-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2024.155699
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Unveiling the neuroprotection effects of Volvalerenic acid A: Mitochondrial fusion induction via IDO1-mediated Stat3-Opa1 signaling pathway.

    Ge, Shanchun / Wang, Lei / Jin, Chang / Xie, Haifeng / Zheng, Guoping / Cui, Zhengguo / Zhang, Chaofeng

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2024  Volume 129, Page(s) 155555

    Abstract: Background: Ischemic stroke is a leading cause of death and long-term disability worldwide. Studies have suggested that cerebral ischemia induces massive mitochondrial damage. Valerianic acid A (VaA) is the main active ingredient of valerianic acid with ...

    Abstract Background: Ischemic stroke is a leading cause of death and long-term disability worldwide. Studies have suggested that cerebral ischemia induces massive mitochondrial damage. Valerianic acid A (VaA) is the main active ingredient of valerianic acid with neuroprotective activity.
    Purpose: This study aimed to investigate the neuroprotective effects of VaA with ischemic stroke and explore the underlying mechanisms.
    Method: In this study, we established the oxygen-glucose deprivation and reperfusion (OGD/R) cell model and the middle cerebral artery occlusion and reperfusion (MCAO/R) animal model in vitro and in vivo. Neurological behavior score, 2, 3, 5-triphenyl tetrazolium chloride (TTC) staining and Hematoxylin and Eosin (HE) Staining were used to detect the neuroprotection of VaA in MCAO/R rats. Also, the levels of ROS, mitochondrial membrane potential (MMP), and activities of NAD
    Results: We showed that VaA decreased the infarct volume in a dose-dependent manner and exerted neuroprotective effects against reperfusion injury. Furthermore, VaA promoted Opa1-related mitochondrial fusion and reversed neuronal mitochondrial damage and loss after reperfusion injury. In SH-SY5Y cells, VaA (5, 10, 20 μM) exerted similar protective effects against OGD/R-induced injury. We then examined the expression of significant enzymes regulating the kynurenine (Kyn) pathway of the ipsilateral brain tissue of the ischemic stroke rat model, and these enzymes may play essential roles in ischemic stroke. Furthermore, we found that VaA can bind to the initial rate-limiting enzyme IDO1 in the Kyn pathway and prevent Stat3 phosphorylation, promoting Stat3 activation and subsequent transcription of the mitochondrial fusion-related gene Opa1. Using in vivo IDO1 knockdown and in vitro IDO1 overexpressing models, we demonstrated that the promoted mitochondrial fusion and neuroprotective effects of VaA were IDO1-dependent.
    Conclusion: VaA administration improved neurological function by promoting mitochondrial fusion through the IDO1-mediated Stat3-Opa1 pathway, indicating its potential as a therapeutic drug for ischemic stroke.
    Language English
    Publishing date 2024-03-20
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2024.155555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Catalytic self-transfer hydrogenolysis of lignin with endogenous hydrogen: road to the carbon-neutral future

    Shen, Xiaojun / Zhang, Chaofeng / Han, Buxing / Wang, Feng

    Chemical Society reviews. 2022 Mar. 7, v. 51, no. 5

    2022  

    Abstract: Due to the depletion of fossil sources, it is imperative to develop a sustainable and carbon-neutral biorefinery for supporting the fuel and chemical supply in modern society. Lignin, the only renewable aromatic source, is still an underutilized ... ...

    Abstract Due to the depletion of fossil sources, it is imperative to develop a sustainable and carbon-neutral biorefinery for supporting the fuel and chemical supply in modern society. Lignin, the only renewable aromatic source, is still an underutilized component in lignocellulose. Very recently, it has been found that hydrogenolysis is a promising technology for lignin valorization. However, high-pressure H₂ is necessary during lignin hydrogenolysis, resulting in safety problems. Furthermore, H₂ is mainly produced from steam reforming of fossil sources in industry, which makes the conversion of renewable lignin unsustainable and costly. Plentiful aliphatic hydroxyl and methoxy groups exist in native lignin and offer a renewable alternative to H₂, and can be hydrogen sources for the depolymerization and upgradation of lignin via the intramolecular catalytic transfer hydrogenation. The hydrogen source in situ generated from lignin is a type of green hydrogen, decreasing the carbon footprint. The purpose of this review is to provide a summary and perspective of lignin valorization via self-transfer hydrogenolysis, mainly focusing on a comprehensive understanding of the mechanism of catalytic self-transfer hydrogenolysis at the molecular level and developing highly effective catalytic systems. Moreover, some opportunities and challenges within this attractive field are given to discuss future research directions.
    Keywords biorefining ; carbon footprint ; depolymerization ; hydrogen ; hydrogenation ; industry ; lignin ; lignocellulose ; steam
    Language English
    Dates of publication 2022-0307
    Size p. 1608-1628.
    Publishing place The Royal Society of Chemistry
    Document type Article
    ZDB-ID 1472875-8
    ISSN 1460-4744 ; 0306-0012
    ISSN (online) 1460-4744
    ISSN 0306-0012
    DOI 10.1039/d1cs00908g
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Recent advances of LSD1/KDM1A inhibitors for disease therapy.

    Zhang, Chaofeng / Wang, Zhiyuan / Shi, Yuting / Yu, Bin / Song, Yihui

    Bioorganic chemistry

    2023  Volume 134, Page(s) 106443

    Abstract: Lysine-specific demethylase 1 (LSD1/KDM1A) dysregulation is closely associated with the pathological processes of various diseases, especially hematologic malignancies. Significant progresses have been made in the field of LSD1-targeted drug discovery. ... ...

    Abstract Lysine-specific demethylase 1 (LSD1/KDM1A) dysregulation is closely associated with the pathological processes of various diseases, especially hematologic malignancies. Significant progresses have been made in the field of LSD1-targeted drug discovery. Nine LSD1 inhibitors including tranylcypromine, ORY-1001, ORY-2001, GSK-2879552, IMG-7289, INCB059872, TAK-418, CC-90011 and SP-2577 have entered clinical stage for disease treatment as either mono- or combinational therapy. This review updates LSD1 inhibitors reported during 2022. Design strategies, structure-activity relationship studies, binding model analysis and modes of action are highlighted. In particular, the unique multiple-copies binding mode of quinazoline derivatives paves new ways for the development of reversible LSD1 inhibitors by blocking the substrate entrance. The design strategy of clinical candidate TAK-418 also provides directions for further optimization of novel irreversible LSD1 inhibitors with low hematological side effects. The influence of the stereochemistry on the potency against LSD1 and its homolog LSD2 is briefly discussed. Finally, the challenges and prospects of LSD1-targeted drug discovery are also given.
    MeSH term(s) Antineoplastic Agents/pharmacology ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Structure-Activity Relationship ; Histone Demethylases
    Chemical Substances Antineoplastic Agents ; TAK-418 (LVM0PK6IHG) ; Enzyme Inhibitors ; Histone Demethylases (EC 1.14.11.-)
    Language English
    Publishing date 2023-02-24
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 120080-x
    ISSN 1090-2120 ; 0045-2068
    ISSN (online) 1090-2120
    ISSN 0045-2068
    DOI 10.1016/j.bioorg.2023.106443
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top